Priyanka Jhalora
Research Subjects
Research Interests
Priyanka Jhalora has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Latest Publications
- Open Access
- 31 July 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 35 (8) , 1921-1926
Synthesis, Characterization and Biological Evaluation of Novel Methoxy Benzaldehyde Substituted Derivatives of Pyrazolopyrimidine-4-hydrazide
Several novel pyrrolopyrimidine derivatives of methoxybenzaldehydes with biologically active pyrrole moieties were synthesized to investigate their antibacterial, antifungal and cytotoxic activities. Elemental analysis, UV-spectra, FT-IR, 1H NMR and 13C NMR spectra, were used to characterize the synthesized compounds. The in vitro antifungal and antibacterial activities were tested for all the synthesized compounds. Compared to the reference drugs e.g. fluconazole and streptomycin, most of the compounds tested positive for antifungal and antibacterial activity. All tested compounds demonstrated superior cytotoxic activity to the reference drug doxorubicin, with IC50 values ranging from 6.52 to 7.77 mM and comparable activity with IC50 values of 8.21 and 8.27 mM, respectively. In vitro antibacterial and antifungal activities revealed that the compouds b and e were more effective than the standard drugs streptomycin and fluconazole, respectively.
- 31 July 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 35 (8) , 1921-1926
Open AccessSynthesis, Characterization and Biological Evaluation of Novel Methoxy Benzaldehyde Substituted Derivatives of Pyrazolopyrimidine-4-hydrazide
Several novel pyrrolopyrimidine derivatives of methoxybenzaldehydes with biologically active pyrrole moieties were synthesized to investigate their antibacterial, antifungal and cytotoxic activities. Elemental analysis, UV-spectra, FT-IR, 1H NMR and 13C NMR spectra, were used to characterize the synthesized compounds. The in vitro antifungal and antibacterial activities were tested for all the synthesized compounds. Compared to the reference drugs e.g. fluconazole and streptomycin, most of the compounds tested positive for antifungal and antibacterial activity. All tested compounds demonstrated superior cytotoxic activity to the reference drug doxorubicin, with IC50 values ranging from 6.52 to 7.77 mM and comparable activity with IC50 values of 8.21 and 8.27 mM, respectively. In vitro antibacterial and antifungal activities revealed that the compouds b and e were more effective than the standard drugs streptomycin and fluconazole, respectively.